Department of Hepatology, University Hospital Gasthuisberg, Leuven, Belgium.
J Hepatol. 2010 Jul;53(1):213-7. doi: 10.1016/j.jhep.2010.03.002. Epub 2010 Apr 10.
The development of hepatocellular adenomas and - more rarely - carcinoma in the liver of patients with Glycogen Storage Disease type Ia (GSDIa) is a well-known complication of the disease. The pathophysiology of adenoma and carcinoma development in these patients is, however, hitherto largely unknown and is thought to be related to the metabolic control of the patient and/or the type of mutations in the G6PC gene. We report here on a very illustrative case of adenoma and carcinoma formation in a previously undiagnosed 42 year old male GSDIa patient (enzymatically and genetically proven). He had two episodes of mild hypoglycaemia in childhood, never required formal treatment, showed normal growth, and only mild lactate increases after prolonged starvation. He was a long-distance runner for most of his adult life, without the need for more than normal carbohydrate intake before/during exertion. To gain a better view on the type of adenoma formed in this patient, molecular studies were performed. We show here that in this patient with mild GSDIa without recurrent hypoglycaemic episodes, adenoma and carcinoma formation still occurred and that malignant transformation of adenoma here is associated with CTNNB1 mutations and a typical mRNA profile of a beta-catenin activated lesion.
糖原贮积病 Ia 型(GSDIa)患者的肝脏中肝细胞腺瘤和 - 更罕见 - 癌的发展是该疾病的已知并发症。然而,这些患者中腺瘤和癌发展的病理生理学迄今为止在很大程度上尚不清楚,被认为与患者的代谢控制和/或 G6PC 基因突变类型有关。我们在此报告了一例非常有代表性的病例,即一名先前未诊断出的 42 岁 GSDIa 男性患者(酶学和遗传学证实)发生了腺瘤和癌的形成。他在儿童时期有两次轻度低血糖发作,从未需要正式治疗,生长正常,仅在长时间禁食后乳酸盐增加。他在成年后的大部分时间里都是长跑运动员,在运动前/期间无需摄入比正常水平更多的碳水化合物。为了更好地了解该患者形成的腺瘤类型,进行了分子研究。我们在此表明,在这名没有反复发作低血糖发作的轻度 GSDIa 患者中,仍然发生了腺瘤和癌的形成,并且腺瘤的恶性转化与 CTNNB1 突变和典型的 beta-catenin 激活病变的 mRNA 特征相关。